Mgo One Seven LLC Cassava Sciences Inc Transaction History
Mgo One Seven LLC
- $2.95 Billion
- Q2 2025
A detailed history of Mgo One Seven LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Mgo One Seven LLC holds 16,757 shares of SAVA stock, worth $36,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,757
Previous 15,448
8.47%
Holding current value
$36,530
Previous $23,000
30.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SAVA
# of Institutions
144Shares Held
15MCall Options Held
1.67MPut Options Held
1.26M-
Black Rock Inc. New York, NY3.22MShares$7.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$4.73 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny909KShares$1.98 Million0.0% of portfolio
-
State Street Corp Boston, MA874KShares$1.91 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$1.72 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $87.4M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...